Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

Deal Watch table for June 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during June 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Publicis Life Brands Resolute hires Simon Goldsborough

Latest recruit brings more than 10 years in-house and agency experience

- PMLiVE

Results Healthcare appoints senior analyst

Carrie Yang will provide venture capital and business strategy experience

- PMLiVE

J&J files ‘breakthrough’ drug ibrutinib in US

FDA to assess drug in lymphoma and leukaemia

- PMLiVE

Court orders EC to approve rejected orphan medicine

Says CTRS should be allowed to market Orphacol for the treatment of rare bile condition

- PMLiVE

Revlimid faces NICE rejection for use in rare blood cancer

Watchdog's draft guidance does not recommend Celgene's drug for NHS use in England and Wales

Novartis sponsors rare disease patient community

Backs site for patients affected by pancreatic neuroendocrine tumours (PNET)

- PMLiVE

Pfizer wins new European approval for Prevenar 13

Expands use of pneumococcal disease vaccine to cover people aged 18 to 49

- PMLiVE

Cytori appoints David Rickey as chairman

Replaces Lloyd Dean who will concentrate on CEO position at Dignity Health

- PMLiVE

The marketer’s role in early drug development

Why as a marketer you can do much to enable your R&D colleagues to find a product’s added value

- PMLiVE

EMA in firing line as transparency debate widens

Swedish regulator claims EU agency withheld information on drug withdrawn from sale in 2008

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links